Effects of Endo-Radifrequency (endo RF) treatment patients with hidradenitis suppurativa
Phase 2
Recruiting
- Conditions
- L73.2Hidradenitis suppurativa.Hidradenitis suppurativa
- Registration Number
- IRCT20150825023753N24
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Patients with moderate to severe cases (Hurley Stage) of HS disease according to clinical evidence
Having Informed consent to participate in the study
Age above 18 years old
Exclusion Criteria
Patients with active infection at the procedure site
Patients allergic to anesthetics
Patients with a cardiac pacemaker
Patients with metallic implants
Pregnant and lactating women
Patients with unilateral lesions
Receiving anticoagulant and antiplatelet drugs
Performing surgery at the procedure site
Patients with underlying autoimmune disease, malignancy and immunodeficiency
Phobia about treatment with RF
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the recovery of lesions from the doctor's point of view. Timepoint: Start studying, the end of the second, fourth and eighth weeks. Method of measurement: Impression of improvement (CGI-I).;Overall improvement rate from the patient's point of view. Timepoint: Start studying, the end of the second, fourth and eighth weeks. Method of measurement: Patient global impression of improvement(PGA).;Assessment of recovery process. Timepoint: Start studying, the end of the second, fourth and eighth weeks. Method of measurement: Using HiSCR Score.
- Secondary Outcome Measures
Name Time Method